The antibiotic paradox

Antibiotic Policies: Controlling Hospital Acquired Infection

Volumn 9781441917348, Issue , 2012, Pages 15-25

  Gould, Ian M ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

ESBL; HAI; MRSA; Resistance; Toxins; Virulence

Indexed keywords

EID: 84930036426     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-1734-8_2     Document Type: Chapter

References (31)

1. Gould IM. Alexander Gordon, puerperal sepsis, and modern theories of infection control-Sem-melweis in perspective. Lancet Infect Dis. 2010;10:275-278.
2. Williams K. Reappraising Florence Nightingale. Br Med J. 2008;337:1461-1466.
3. Lister J. On a new method of treating compound fracture, abscess, etc. with observations on the conditions of suppuration. Lancet 1867, March 16;326-9.
4. http://www.idsociety.org/(last accessed 14th October, 2010)
5. Washer P, Joffe H, Solberg C. Audience readings of media messages about MRSA. J Hosp Infect 2008;70:42
6. Spellberg B. Dr William H Stewart: mistaken or maligned? Clin Infect Dis. 2008;47:294
7. Gould IM. Antibiotic policies to control hospital-acquired infection. J Antimicrob. Chemother. 2008;61:763-5.
8. Gould IM. Controversies in infection: infection control or antibiotic stewardship to control healthcare-acquired infection. J Hosp Infect. 2009;73:Suppl 3:S2-6.
9. Karas JA, Enoch DA, Aliyu SH. A review of mortality due to Clostridium difficile infection. J Hosp Infect. 2010;61:1-8.
10. Gould IM. Community-acquired MRSA: can we control it? Lancet 2006;368:824-6.
11. Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis 2005;11:1965-1966.
12. Run chart of quarterly number of S.aureus bacteraemia in Scotland, 1 April 2005 to 31 March 2009 with HEAT target trajectory to 31 March 2010. HAI Newsletter, HPS Aug '09-Jan '10 vol 6 issue 2.
13. Monnet DL, MacKenzie FM, Lopez-Lozano JM, Beyaert A, Camacho M, Wilson R, Stuart D Gould IM. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus Aberdeen 1996-2000. Emerg Infect Dis 2004;10:1432-41.
14. Gould IM. Clinical relevance of increasing glycopeptides MICs against Staphylococcus aureus. Int J Antimicrob Agents 2008;31:1-9.
15. www.rivm.nl/earss/(last accessed 14th October, 2010)
16. www.eucast.org/(last accessed 14th October, 2010)
17. Avgeri SG, Matthaiou DK, Dimopoulos G, Grammatikos AP, Falagas ME. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systemic review of the clinical evidence. Int J Antimicrob Agents 2009;33:394-404.
18. Gabriel PS, Zhou J, Tabibi S, Chen Y, Trauzzi M. & Saiman L. Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis. Int J Antimicrob Agents 2004;48:168-171.
19. Fournier P, Vallenet D, Barbe V, Audic S, Ogata H, Poiret L, Richet H et al. Comparative Genom-ics of Multidrug Resistance in Acinetobacter baumannii. PLoS Genetics 2006 2 (1) e7 62-72.
20. Gould IM. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents 2009;34:Suppl 3:S2-5.
21. Kumarasumy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological and epidemiological study. The Lancet Published online August 11, 2010.
22. Levin BR. Minimizing potential resistance: A population dynamics view. Clin Infect Dis 2001;33: (suppl 3).S161-169.
23. Lindsay J. & Holden M. Staphylococcus aureus: Superbug, super genome? Trends Microbiol. 2004;12:378-385.
24. Kumar A, Roberts D, Wood KE, Light B, Parillo JE, Sharma S, Suppes R, Feinstein R, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 2006;34:1589-1596.
25. Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B. McGregor JC. Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection. Antimicrob. Agents & Chemother. 2007;51:3510-3515.
26. Whitby M, McLaws M, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis Med J Aust 2001;175:264-267.
27. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with meth-icillin-resistant and methicillinsusceptible Staphylococcus aureus bacteremia: a meta analysis. Clin Infect Dis 2003;36:53-59.
28. Berntsen C, McDermott W. Increased transmissibility of staphylococci to patients receiving an antimicrobial drug. N Engl J Med 1960;262:637-642.
29. Cheng YM, Li WC, Huang CT, Huang CG, Tsao KC, Cheng YH, Chiang SL, Yang SY, Chen CH & Huang YC. Use of oseltamivir during an outbreak of influenza A in a long term care facility in Taiwan. J Hosp Infect 2008;68:83-87.
30. Reilly JS, Stewart S, Christie P, Allardice G, Smith A, Masterton R, Gould IM, Williams C. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project. J Hosp Infect 2010;74:35-41.
31. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M & Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev. 2005; Oct 19 (4):CD003543